Accessibility StatementSkip Navigation Caitlin AdorniDirector of Portfolio & Institutional Client Monitoring ServicesBerger Montague(267) 764- 4865[email protected] SOURCE Berger Montague WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? On September 28, 2025, the Company announced Phase 3 clinical trial results for SLK, which, according to the lawsuit, showed that SLK failed to achieve efficacy comparable to BIMZELX. Analysts reportedly described the data as a "disastrous result," and MoonLake's st ...